Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing

Abstract

Recently, it has become increasingly evident that fracture healing involves a complex interaction of many local and systemic regulatory factors. The roles of some of these growth factors have been described; however, little is understood about the presence of the bone morphogenetic proteins in fracture repair, despite the fact that they are the most potent osteoinductive proteins known. This study defines and characterizes the physiologic presence, localization, and chronology of the bone morphogenetic proteins in fracture healing with an established rat fracture healing model. With use of a recently developed monoclonal antibody against bone morphogenetic proteins 2 and 4 developed with standard avidin-biotin complex/immunoperoxidase protocols, frozen undecalcified fracture calluses were analyzed semiquantitatively for the percentage of various types of fracture cells staining positively. During the early stages of fracture healing, only a minimum number of primitive cells stained positively in the fracture callus. As the process of endochondral ossification proceeded, the presence of bone morphogenetic proteins 2 and 4 increased dramatically, especially in the primitive mesenchymal and chondrocytic cells. While the cartilaginous component of the callus matured with a concomitant decrease in the number of primitive cells, there was a concomitant decrease in both the intensity and the number of positively staining cells. As osteoblasts started to lay down woven bone on the chondroid matrix, these osteoblastic cells exhibited strong positive staining. The intensity of this staining decreased, however, as lamellar bone replaced the primitive woven bone. A similar observation was noted for the areas of the callus undergoing intramembranous ossification. Initially, within several days after the fracture, periosteal cells and osteoblasts exhibited intense staining for bone morphogenetic proteins 2 and 4. As the woven bone was replaced with mature lamellar bone, this staining decreased. These data, and the awareness of the strong osteoinductive capacities of bone morphogenetic protein, suggest that bone morphogenetic proteins 2 and 4 are important regulators of cell differentiation during fracture repair.

Novel Wnt Regulator NEL-Like Molecule-1 Antagonizes Adipogenesis and Augments Osteogenesis Induced by Bone Morphogenetic Protein 2

“…75,76 In contrast, we have shown that NELL-1 treatment alone can induce complete defect healing using a demineralized bone matrix carrier, which contains residual BMPs. 37,77 Finally, using a femoral onlay model, 12 we found that NELL-1 does not mediate inflammatory cell infiltration, in contrast to BMP2.…”

Bone tissue engineering: A review in bone biomimetics and drug delivery strategies

“…Several researchers have reported on the sequential cellular production and expression of multiple growth factors in preclinical fracture healing experiments. 287,288 Multiple researchers have also observed a synergistic effect (i.e., enhance bone formation) from local sequential administration of multiple growth factors on osteoprogenitor and osteoblast cells in vitro and in vivo. [289][290][291][292] Despite this, many synthetic bone scaffolds rely on the delivery of single factors, which may partially explain the limited clinical utility of many current approaches.…”

Pro-inflammatory Cytokine Tumor Necrosis Factor-α Induces Bone Morphogenetic Protein-2 in Chondrocytes via mRNA Stabilization and Transcriptional Up-regulation

“…The growth factor is expressed in the process of bone healing where it regulates cellular differentiation, proliferation, and matrix production (7,8). Various tumors have been found to express BMP-2.…”